Lloyd Price

AUGUST 23, 2018

Interoperability is an overlapping set of technical and policy challenges, from data access to common data models to information exchange to workflow integration – and these challenges often pose a barrier to healthcare innovation. Today, as health IT community leaders get together at the CMS Blue Button 2.0

Interoperability 42

Interoperability FHIR EHR Health Data 42

Healthcare IT Today

SEPTEMBER 29, 2022

NYeC supports providers in navigating the complex landscape of healthcare information technology provider assistance programs, practice transformation, vendor selection, Promoting Interoperability (formerly Meaningful Use) attestation, and health information exchange utilization.

Health IT 98

Health IT eHealth Meaningful Use Health Information 98

Healthcare IT Today

JANUARY 5, 2023

NYeC supports providers in navigating the complex landscape of healthcare information technology provider assistance programs, practice transformation, vendor selection, Promoting Interoperability (formerly Meaningful Use) attestation, and health information exchange utilization.

Health IT 91

Health IT eHealth Meaningful Use Health Information 91

Health Blawg

APRIL 2, 2018

This selection focuses on interoperability, the patient matching technology that undergirds aspects of interoperability, and the benefits of these technologies in the development of tools to manage patient journeys in a manner that engages patients, caregivers and providers as partners in care, advancing the quadruple aim.

Interoperability 60

Interoperability HIE Meaningful Use Healthcare Innovation 60

Health Blawg

APRIL 2, 2018

This selection focuses on interoperability, the patient matching technology that undergirds aspects of interoperability, and the benefits of these technologies in the development of tools to manage patient journeys in a manner that engages patients, caregivers and providers as partners in care, advancing the quadruple aim.

Interoperability 60

Interoperability HIE Meaningful Use Healthcare Innovation 60

mHealth Insight

SEPTEMBER 6, 2019

Simultaneously, these biomarkers must be of sufficient direct value to patients to justify their participation in the data-collection effort. Greater investment in the science of digital biomarkers is needed to evaluate the value of mobile health data for clinical use. None of this is easy.

Mobile Health 48

Mobile Health mHealth EHR FHIR 48